Immune Therapeutics, Inc. Note Agreements

30 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Promissory note to Robert J. Dailey, issued March 7, 2014 for $200,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2014
First Amendment to Promissory Note between Immune Therapeutics, Inc. and Ira Gaines dated November 4, 2022
Note Agreements
Immune Therapeutics, Inc.
2024
First Amendment to Promissory Note between Immune Therapeutics, Inc. and Ira Gaines dated November 4, 2022
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2023
Convertible Promissory Note in the Principal Amount of $200,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2022
Convertible Promissory Note in the Principal Amount of $100,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2022
Convertible Promissory Note in the Principal Amount of $100,000, dated July 19, 2022, between Immune Therapeutics, Inc. and Kevin Phelps
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2022
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Robert J. Dailey
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Note Assignment dated November 10, 2020 between Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Note Purchase Agreement dated November 10, 2020 entered into by Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2022
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Robert J. Dailey
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Promissory Note dated March 11, 2021 between Immune Therapeutics, Inc., and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Note Assignment dated November 10, 2020 between Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Note Purchase Agreement dated November 10, 2020 entered into by Iliad Research and Trading, L.P. and Global Reverb Corporation
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2021
Securities Purchase Agreement dated as of June 15, 2020 with Geneva Roth Remark Holdings, Inc, together with Exhibit A Convertible Promissory Note in the principal amount of...
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement dated as of May 4, 2020 with Geneva Roth Remark Holdings, Inc, together with Exhibit A Convertible Promissory Note in the principal amount of $53,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2020
Convertible Promissory Note dated March 30, 2020 to Redstart Holdings Corp. in the principal amount of $53,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2020
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2020
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2019
Promissory Note dated February 27, 2019 to Phoenix Group in the principal amount of $231,478.39
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2019
Promissory Note dated April 5, 2017 to Robert J. Dailey in the principal amount of $150,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Promissory Note dated February 6, 2017 issued to Phoenix Fund Management, LLC
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Promissory Note Settlement Agreement, dated September 26, 2014, between Immune Therapeutics, Inc. and Robert Dailey for notes equaling $400,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Promissory Note Settlement Agreement, dated September 26, 2014, between Immune Therapeutics, Inc. and Robert Dailey for notes equaling $399,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2018
Securities Purchase Agreement and Note with Iliad Research & Trading LP dated October 20, 2017
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
2017
PROMISSORY NOTE SETTLEMENT AGREEMENT
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2015
PROMISSORY NOTE SETTLEMENT AGREEMENT
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
FL
2015
Promissory note to Robert J. Dailey, issued March 28, 2014 for $200,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2014
Promissory note to Robert J. Dailey, issued February 6, 2014 for $200,000
Note Agreements
Immune Therapeutics, Inc.
Biotechnology
NY
2014